Viridian Therapeutics, Inc.\DE short interest in 2023
In 2023, Viridian Therapeutics, Inc.\DE's disclosed short interest ran from 6.08% of shares outstanding on 13 Jan 2023 to 16.46% on 29 Dec 2023, a change of +10.38 percentage points. The year's high was 21.66% on 31 Aug 2023 and its low 5.88% on 31 Jan 2023, averaging 13.61% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.35 days on 31 Aug 2023. Full history: Viridian Therapeutics, Inc.\DE.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 6.08% (13 Jan 2023)
- End of year
- 16.46% (29 Dec 2023)
- Change
- +10.38 pp
- High
- 21.66% (31 Aug 2023)
- Low
- 5.88% (31 Jan 2023)
- Average
- 13.61%
- Highest days to cover
- 24.35 (31 Aug 2023)
- SEC filings marked
- 7
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 6.08% | 2.78 | |
| 31 Jan 2023 | 5.88% | 4.84 | |
| 15 Feb 2023 | 6.62% | 5.66 | |
| 28 Feb 2023 | 6.60% | 5.62 | |
| 15 Mar 2023 | 6.49% | 4.79 | results (8-K), 10-K filed |
| 31 Mar 2023 | 8.04% | 6.14 | |
| 14 Apr 2023 | 8.28% | 7.38 | |
| 28 Apr 2023 | 8.13% | 5.82 | |
| 15 May 2023 | 10.17% | 5.91 | results (8-K), 10-Q filed |
| 31 May 2023 | 13.27% | 8.96 | |
| 15 Jun 2023 | 14.14% | 10.75 | |
| 30 Jun 2023 | 15.74% | 6.94 | |
| 14 Jul 2023 | 17.46% | 6.33 | |
| 31 Jul 2023 | 14.51% | 8.20 | |
| 15 Aug 2023 | 19.83% | 13.54 | 10-Q filed |
| 31 Aug 2023 | 21.66% | 24.35 | |
| 15 Sep 2023 | 21.39% | 11.74 | |
| 29 Sep 2023 | 21.61% | 21.68 | |
| 13 Oct 2023 | 17.49% | 8.82 | |
| 31 Oct 2023 | 18.69% | 9.21 | |
| 15 Nov 2023 | 15.75% | 8.92 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 16.17% | 12.22 | |
| 15 Dec 2023 | 16.09% | 8.92 | |
| 29 Dec 2023 | 16.46% | 8.43 |
See also: Viridian Therapeutics, Inc.\DE's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.